PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $202,181 | -21.9% | 6,590 | +2.0% | 0.11% | -24.2% |
Q2 2023 | $258,852 | +1.8% | 6,460 | +3.7% | 0.15% | -3.2% |
Q1 2023 | $254,246 | +13.0% | 6,230 | +7.0% | 0.15% | +4.8% |
Q4 2022 | $224,903 | -22.4% | 5,825 | +6.8% | 0.15% | -30.0% |
Q3 2022 | $290,000 | +4733.3% | 5,455 | +5355.0% | 0.21% | +6900.0% |
Q4 2021 | $6,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |